BRPI0407116A - Partìcula revestida baseada em princìpio ativo, composição farmacêutica ou cosmética, e, método para produção de partìcula revestida com princìpio ativo - Google Patents

Partìcula revestida baseada em princìpio ativo, composição farmacêutica ou cosmética, e, método para produção de partìcula revestida com princìpio ativo

Info

Publication number
BRPI0407116A
BRPI0407116A BR0407116-6A BRPI0407116A BRPI0407116A BR PI0407116 A BRPI0407116 A BR PI0407116A BR PI0407116 A BRPI0407116 A BR PI0407116A BR PI0407116 A BRPI0407116 A BR PI0407116A
Authority
BR
Brazil
Prior art keywords
particle
coated particle
active principle
active
pharmaceutical
Prior art date
Application number
BR0407116-6A
Other languages
English (en)
Inventor
Philippe Chenevrier
Dominique Marechal
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of BRPI0407116A publication Critical patent/BRPI0407116A/pt
Publication of BRPI0407116B1 publication Critical patent/BRPI0407116B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/003—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic followed by coating of the granules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
    • Y10T428/2998—Coated including synthetic resin or polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

"PARTìCULA REVESTIDA BASEADA EM PRINCìPIO ATIVO, COMPOSIçãO FARMACêUTICA OU COSMéTICA, E, MéTODO PARA PRODUçãO DE PARTìCULA REVESTIDA COM PRINCìPIO ATIVO". Partícula revestida baseada em princípio ativo na qual ambos, o núcleo e o revestimento, contêm princípio ativo, na qual o núcleo contém um primeiro princípio ativo enquanto o revestimento contém um segundo princípio ativo, o qual é de natureza diferente.
BRPI0407116-6A 2003-02-05 2004-01-21 Partícula revestida baseada em princípio ativo, composição farmacêutica ou cosmética, e, método para produção de partícula revestida baseada em princípio ativo BRPI0407116B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0301308 2003-02-05
FR0301308A FR2850576B1 (fr) 2003-02-05 2003-02-05 Composition comprenant un melange de principes actifs, et procede de preparation
US44719803P 2003-02-13 2003-02-13
US60/447,198 2003-02-13
PCT/EP2004/050035 WO2004069135A2 (en) 2003-02-05 2004-01-21 Composition comprising a mixture of active principles, and method of preparation

Publications (2)

Publication Number Publication Date
BRPI0407116A true BRPI0407116A (pt) 2006-01-10
BRPI0407116B1 BRPI0407116B1 (pt) 2018-04-03

Family

ID=32852330

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407116-6A BRPI0407116B1 (pt) 2003-02-05 2004-01-21 Partícula revestida baseada em princípio ativo, composição farmacêutica ou cosmética, e, método para produção de partícula revestida baseada em princípio ativo

Country Status (18)

Country Link
US (2) US7846460B2 (pt)
EP (1) EP1589954B1 (pt)
JP (1) JP4791348B2 (pt)
KR (1) KR20050096963A (pt)
CN (1) CN1747723B (pt)
AU (1) AU2004210438B2 (pt)
BR (1) BRPI0407116B1 (pt)
CA (1) CA2514446C (pt)
EA (1) EA010972B1 (pt)
ES (1) ES2590807T3 (pt)
FR (1) FR2850576B1 (pt)
IL (1) IL169880A (pt)
IS (1) IS7998A (pt)
MX (1) MXPA05008161A (pt)
NO (1) NO341294B1 (pt)
NZ (1) NZ541886A (pt)
PL (1) PL223347B1 (pt)
WO (1) WO2004069135A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI365880B (en) 2004-03-30 2012-06-11 Euro Celtique Sa Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp
US8163114B2 (en) * 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
BRPI0614143A2 (pt) 2005-08-02 2012-11-20 Sol Gel Technologies Ltd processo para revestir um material particulado insolével em Água, sàlido, com um àxido metÁlico, material particulado revestido, composiÇço, mÉtodo para o tratamento de uma condiÇço superficial em um induvÍduo, e, uso de material particulado revestido
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
MX2009001294A (es) 2006-08-04 2009-05-21 Ethypharm Sa Granulo y tableta que se desintegra por vía oral que comprende oxicodona.
RU2487703C2 (ru) * 2006-09-26 2013-07-20 Новартис Аг Фармацевтические композиции, включающие модулятор s1р
WO2008089774A1 (fr) * 2007-01-22 2008-07-31 Crd Saidal Formulation d'un comprime orodispersible a base de paracetamol enrobe
EA200970724A1 (ru) 2007-02-01 2010-02-26 Сол-Джел Текнолоджиз Лтд. Композиции для местного применения, содержащие пероксид и ретиноид
ES2763829T3 (es) 2007-02-01 2020-06-01 Sol Gel Tech Ltd Método para preparar partículas que comprenden un revestimiento de óxido de metal
JP5356255B2 (ja) * 2007-12-27 2013-12-04 大鵬薬品工業株式会社 経口粉粒状抗腫瘍剤
RU2567032C2 (ru) * 2009-05-01 2015-10-27 Апталис Фарматек, Инк. Перорально распадающиеся таблеточные композиции, содержащие комбинации неопиоидных и опиоидных анальгетиков
CN102526124B (zh) * 2011-01-31 2013-11-20 成都科尔医药技术有限公司 一种中药粉体及其制备方法
TW201722406A (zh) 2012-03-02 2017-07-01 羅德製藥公司 抗破壞性立即釋出型調製劑類
JP6320297B2 (ja) * 2012-09-13 2018-05-09 ライオン株式会社 発泡性口腔用組成物、発泡性口腔用固形製剤及び発泡性口腔用製品
CA2888278A1 (en) * 2012-10-15 2014-04-24 Isa Odidi Oral drug delivery formulations
KR101484608B1 (ko) * 2012-11-26 2015-01-22 한국과학기술연구원 Pva와 알지네이트 기반 코어-쉘 구조의 복합담체 및 그 제조방법
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
WO2014120922A1 (en) 2013-02-01 2014-08-07 W. R. Grace & Co.-Conn. Porous silica gel as a carrier for liquid technologies
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
HUE073201T2 (hu) 2017-07-12 2026-01-28 Sol Gel Tech Ltd Kapszulázott tretinoint tartalmazó készítmények
CN111990641A (zh) * 2020-05-06 2020-11-27 焦作百仑斯生物科技有限公司 一种解酒护肝片及施工方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000044404A (ja) * 1998-07-27 2000-02-15 Otsuka Chem Co Ltd 農業用混合粒剤
CA2259727A1 (en) * 1999-01-18 2000-07-18 Bernard Charles Sherman A two-layer pharmaceutical tablet comprising an nsaid and misoprostol
US6451342B2 (en) * 2000-05-01 2002-09-17 Aeropharm Technology Incorporated Core formulation comprised of troglitazone and a biguanide
US6296874B1 (en) * 2000-05-01 2001-10-02 Aeropharm Technology Incorporated Core formulation comprising troglitazone and abiguanide
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
ES2380827T3 (es) * 2002-12-26 2012-05-18 Pozen, Inc. Formas de dosificación con múltiples capas que contienen naproxeno y triptanes

Also Published As

Publication number Publication date
CN1747723A (zh) 2006-03-15
JP4791348B2 (ja) 2011-10-12
PL376465A1 (en) 2005-12-27
EA010972B1 (ru) 2008-12-30
FR2850576B1 (fr) 2007-03-23
AU2004210438A1 (en) 2004-08-19
BRPI0407116B1 (pt) 2018-04-03
WO2004069135A2 (en) 2004-08-19
EA200501250A1 (ru) 2006-02-24
IL169880A (en) 2013-10-31
NO341294B1 (no) 2017-10-02
IL169880A0 (en) 2007-07-04
EP1589954B1 (en) 2016-08-31
NZ541886A (en) 2008-12-24
PL223347B1 (pl) 2016-10-31
NO20053799L (no) 2005-08-11
US7846460B2 (en) 2010-12-07
US20110081389A1 (en) 2011-04-07
MXPA05008161A (es) 2005-10-05
AU2004210438B2 (en) 2007-08-16
EP1589954A2 (en) 2005-11-02
IS7998A (is) 2005-08-25
CN1747723B (zh) 2010-05-12
HK1087015A1 (zh) 2006-10-06
JP2006516597A (ja) 2006-07-06
KR20050096963A (ko) 2005-10-06
WO2004069135A3 (en) 2004-10-28
US20060134422A1 (en) 2006-06-22
CA2514446C (en) 2012-04-10
ES2590807T3 (es) 2016-11-23
FR2850576A1 (fr) 2004-08-06
CA2514446A1 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
ATE302614T1 (de) Kosmetische oder dermo-pharmazeutische zusammensetzung in form von hydrophoben perlen und herstellungsverfahren
BR0111020B1 (pt) composição de revestimento fotoativável, processo para produção de uma camada de revestimento, e, uso de uma composição de revestimento.
BR9809465A (pt) Composições de cuidados com a pele e método para melhorar a aparência da pele
AU2003221225A1 (en) CaCO3/Si2O " nH2O NANOCOMPOSITE PARTICLES, Si2O " nH2O NANOMATERIAL AND METHOD OF PRODUCING THE SAME
DE60125101D1 (de) Kosmetikauftragevorrichtung bestehend aus zwei zusammengesetzten Einheiten, von denen eine mit Flocken beschichtet ist
MXPA05008161A (es) Composicion que comprende una mezcla de principios activos, y metodo de preparacion.
WO2002074274A3 (en) Oral care kits and compositions
DE60122636D1 (de) Beschichtungszusammensetzungen, deren Herstellung und Verwendung, beschichtete Gegenstände
BR9904039A (pt) Preparação de partìculas farmaceuticamente ativas
BR9707499A (pt) Partículas de dióxido de titânico anatásio processo para preparaç o das partículas utilizaç o das partículas e composiç o cosmética anti-uv
BRPI0416114A (pt) materiais compósitos compreendendo nanopartìculas carregadas com metal
AU2002253126A1 (en) Use of creatine, creatinine and/or derivatives thereof
AU2002339691A1 (en) Agonists and antagonists of prolixin for the treatment of metabolic disorders
DE60105665D1 (de) Beschichtungszusammensetzung, Beschichtungsverfahren und beschichtete Gegenstände
BR9710247A (pt) Partículas de dióxido de titánio anatásio processo para sua fabricação utilização das partículas composição cosmética anti-uv e composição de revestimento anti-uv
FR2828645B1 (fr) Composition cosmetique capillaire contenant de la gomme xanthane, et procede pour sa preparation
WO2000074662A3 (en) Arthritis treatment
BRPI0412971A (pt) método de alongamento do cabelo
DE60323474D1 (de) Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
DE60234346D1 (de) Kosmetischer rohstoff mit verbesserten eigenschaften und verfahren zu seiner herstellung
MXPA05004537A (es) Formulaciones conteniendo melatonina, ginkgo biloba y biotina.
DE60216077D1 (de) Topisches produkt mit visuellem indikator
BR0107485A (pt) Composição cosmética, e, método de conferir às unhas humanas um revestimento cosmético de flexibilidade melhorada, durável e/ou de resistência à transferência
BR0306994A (pt) Produto para aplicação na pele
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 13 E 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2550 DE 19-11-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.